Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation

Table 1 Patients’ baseline characteristics (mean ± SE)

Characteristic	Patients (n = 46)
Sex (M/F)	30/16
Age (yr)	57.9 ± 1.28
Time from OLT (mo)	26.3 ± 5.1
ALT (IU/L)	152.3 ± 17.8
AST (IU/L)	105.9 ± 11.5
Gamma-GT (IU/L)	188.7 ± 39.3
Alkaline phosphatases (IU/L)	364.7 ± 39.9
Bilirubin (mg/L)	1.7 ± 0.37
Viral load (log10)	6.25 ± 0.09
Genotypes 1/4 vs 2/3	36/10
F1/F2/F3/F4	13/16/9/8
Fibrosing cholestatic hepatitis	3
Cyclosporine A vs tacrolimus	7/39

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; Gamma-GT: Gamma-glutamyl transpeptidase; M/F: Male/female.